Debshree Lokhande

A survivor’s take: Why India must ensure a shorter oral regimen to treat drug-resistant TB

By Debshree Lokhande
Published: Nov. 3, 2021, 5:16 p.m.· Tags: Drug-resistant TB, Treatment, Access, TB programs

Despite the emergence of new medicines to treat the disease, the country’s existing health system offers little help in reducing the suffering of patients.

Page 1 of 1 · Total posts: 1